Trials / Unknown
UnknownNCT04102033
Eltrombopag in Chronic ITP
Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia in Pediatrics
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 1 Year – 17 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the efficacy of eltrombopag on the platelet count in pediatric patients with chronic immune thrombocytopenia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Eltrombopag | Thrombopietic agent approved for its efficacy in chronic immune thrombocytopenia in pediatric patients |
Timeline
- Start date
- 2019-11-01
- Primary completion
- 2020-11-01
- Completion
- 2021-01-01
- First posted
- 2019-09-25
- Last updated
- 2019-09-25
Source: ClinicalTrials.gov record NCT04102033. Inclusion in this directory is not an endorsement.